-
, therapy resistance, metastasis, patient-derived organoids, or tissue explants. Cancer Therapeutics: Target discovery and validation, antibody therapeutics, antibody-drug conjugates, engineered cell
-
experimental platform for spatial multi-omic analysis of biological tissues. Our lab builds biological measurement infrastructure—engineering systems that standardize how information is extracted from complex
-
imaging, genetics, omics, EHR data, and clinical outcomes. Ongoing work builds on deep-learning phenotypes from cardiovascular imaging at population scale and extends toward myocardial tissue remodeling
-
the Basic Science and Engineering (BASE) Initiative of the Children's Heart Center at Stanford University and the Department of Genetics to work on understanding mechanisms of pulmonary arterial hypertension
-
for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY27 minimum is $79, 056. Our lab recently developed a new methylation profiling technology, FLEXseq (PMID: 42130071